Specificities and functions of CD4+ HLA class II-restricted T cell clones against a human sarcoma: Evidence for several recognized antigens

Journal of Immunology

Volumn 156, Issue 6, 1996, Pages 2205-2213

  Heike, Michael ^a   Schlaak, Jörg ^a   Schulze Bergkamen, Henning ^a   Heyl, Simone ^a   Herr, Wolfgang ^a   Schmitt, Ute ^a   Schneider, Peter M ^a   Meyer Zum Büschenfelde, Karl Hermann ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; TUMOR NECROSIS FACTOR;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; SARCOMA; T LYMPHOCYTE; TUMOR IMMUNITY;

ABDOMINAL NEOPLASMS; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CLONE CELLS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; MALE; SARCOMA; TUMOR CELLS, CULTURED;

EID: 0029919132     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Dranoff, G., E. Jaffee, A. Lazenby, P Golumbek, H. Levitsky, K Brose, V. Jackson, H. Hamada, D. Pardoll, and R. C. Mulligan. 1993. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90.3539.
2. Levitsky, H. I., A. Lazenby, R. Hayashi, and D. M. Pardoll. 1994. In vivo priming of two distinct anti tumor effector populations: the role of MHC class I expression. J. Exp. Med. 179:1215.
3. Udono, H., D. L. Levey, and P. K Srivastava. 1994. Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo. Proc. Natl. Acad Sci USA 91.3077.
4. + MHC class II restricted T cells that are cytolytic in vitro and tumoricidal in vivo. J. Immunol 1995:4613.
5. Zatloukal, K., A. Schneeberger, M. Berger, W Schmidt, F. Koszik, R. Kutil, M Cotten, E. Wagner, M. Buschle, G. Maass, E. Payer, G. Stingl, and M. L. Birnstiel. 1995. Elicitation of a systemic and protective anti-melanoma immune response by an IL-2 based vaccine. Assessment of critical cellular and molecular parameters. J Immunol. 154:3406.
6. Rohrer, J. W., S. D Rohrer, A. Barsoum, and J. H. Coggin. 1994. Differential recognition of murine tumor associated oncofetal transplantation antigen and individually specific tumor transplantation antigens by syngeneic cloned BALB/C and RFM mouse T cells. J. Immunol 152:754.
7. Awwad, M., and R. I. North. 1990. Radiosensitive barrier to T-cell-mediated adoptive immunotherapy of established tumors. Cancer Res. 50:2228.
8. Martinotti, A., A. Stoppacciaro, M. Vagliani, C Melani, F. Spreafico, M. Wysocka, G Parmiani, G. Trinchieri, and M. P. Colombo. 1995. CD4 T cells inhibit in vivo the CD8 mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes. Eur. J. Immunol. 25:137.
9. Boon, T , J.-C. Cerottini, B. Van den Eynde, P. van der Bruggen, and A. Van Pel. 1994 Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12:337.
10. Van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E De Plaen, B. Van den Eynde, A. Knuth, and T. Boon 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643.
11. Brichard, V., A. Van Pel, T. Wölfel, C. Wölfel, E. De Plaen, B. Lethe, P. Coulie, and T Boon 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489.
12. Coulie, P G., V. Brichard, A. Van Pel, T. Wolfel, J. Schneider, C. Traversari, S. Mattei, E. De Plaen, C. Lurquin, J.-P. Szikora, J.-C. Renauld, and T. Boon. 1994. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180:35.
13. Cox, A. L., J. Skipper, Y. Chen, R A. Henderson, T. L. Darrow, J. Shabanowitz, V. H Engelhard, D. F Hunt, and C. L. Singluff. 1994. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264. 716.
14. Gaugler, B., B. Van den Eynde, P. van der Bruggen, P. Romero, J. J. Gaforio, E. De Plaen, B. Lethe, F. Brasseur, and T. Boon. 1994. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179:921.
15. Kawakami, Y., S. Eliyahu, C. H. Delgado, P F. Robbins, L. Rivoltini, S. L Topalian, T. Miki, and S. A Rosenberg 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl Acad. Sci. USA 91:3515.
16. Kawakami, Y., S Eliyahu, C. H Delgado, P. F. Robbins, K Sakaguchi, E. Appella, J. R. Yannelli, G. J. Adema, T Miki, and S A. Rosenberg. 1994 Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl. Acad Sci. USA 91:6458
17. + T cell clones from regional lymph nodes of melanoma patients. Int. J. Cancer 51:218.
18. Fossati, G , A. Anichini, P. Squarcina, A. Mazzocchi, and G. Parmiani. 1988. Proliferative and/or cytotoxic activity of lymphocyte clones to autologous human melanoma. Int. J. Cancer 42:239.
19. Hom, S S., S. A Rosenberg, and S. L. Topalian. 1993 Specific recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: analysis by cytokine secretion. Cancer Immunol. Immunother. 36.1.
20. Radrizzani, M., B. Benedetti, C. Castelli, A. Longo, G B. Ferrara, M. Herlyn, G, Parmiani, and G. Fossati. 1991 Human allogeneic melanoma-reactive T-helper lymphocyte clones functional analysis of lymphocyte-melanoma interactions. Int. J. Cancer 49:823.
21. Schwartzentruber, D. J., S. L. Topalian, M. Mancini, and S. A Rosenberg. 1991. Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-α, and IFN-γ by human tumor infiltrating lymphocytes after autologous tumor stimulation. J Immunol. 146:3674.
22. Schwartzentruber, D. J., M. Stetler-Stevenson, S. A. Rosenberg, and S. L. Topalian. 1993. Tumor-infiltrating lymphocytes derived from select B-cell lymphomas secrete granulocyte-macrophage colony stimulating factor and tumor necrosis factor-α in response to autologous tumor stimulation. Blood 82:1204.
23. + T lymphocytes against human melanoma: evidence for a shared melanoma antigen presented by HLA-DR15. J Immunol. 154:772.
24. + T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells. Int. J. Cancer 58:69.
25. + T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc Natl. Acad. Sci. USA 91:9461.
26. Wölfel, T , E. Klehman, C. Müller, K.-H. Schütt, K.-H. Meyer zum Büschenfelde, and A. Knuth. 1989. Lysis of human melanoma cells by autologous cytolytic T cell clones. J. Exp. Med. 170:797.
27. Heike, M., O. Rörig, H. E. Gabbert, R. Moll, K.-H. Meyer zum Büschenfelde, W. G. Dippold, and A. Knuth. 1995. New cell lines of gastric and pancreatic cancer, distinct morphology, growth characteristics, expression of epithelial and immunoregulatory antigens. Virchows Arch. 426:375.
28. 2. Cancer Res. 52.3705.
29. Wolfel, T., W. Herr, P. Coulie, U. Schmitt, K.-H. Meyer zum Büschenfelde, and A. Knuth. 1993. Lysis of human pancreatic adenocarcinoma cells by autologous HLA-Class I-restricted cytolytic T-lymphocyte (CTL) clones. Int. J. Cancer 54: 636.
30. Schlaak, J., E. Hermann, M Ringhoffer, P. Probst, H. Gallati, K.-H. Meyer zum Büschenfelde, and B. Fleischer. 1992. Predominance of Th1-type T cells in synovial fluid of patients with Yersinia-induced reactive arthritis. Eur. J. Immunol. 22:2771.
31. Espevik, T., and J. Nissen-Meyer 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99.
32. Schendel, D., and A. Ziegler. 1988. Serological and biochemical characterization of HLA-A molecules bearing a public epitope. Immunogenetics 27:61.
33. Yang, S. Y., Y. Morishima, N. H. Collins, T. Alton, M. S. Pollack, E. J. Yunis, and B. Dupont. 1984. Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and -B allotypes. Immunogenetics 19:217.
34. Herin, M., C. Lemoine, P. Weynants, F Vessiere, A. Van Pel, A. Knuth, R. Devos, and T. Boon. 1987 Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int. J. Cancer 39:390.
35. Hansen, M. B., S. E. Nielsen, and K. Berg. 1989 Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 95:99.
36. Bein, G , R. Glaser, and H. Kirchner. 1992. Rapid HLA-DRB1 genotyping by nested PCR amplification. Tissue Antigens 39:68.
37. + T cells. J. Immunol 155:45.
38. Maass, G , W. Schmidt, M. Berger, F Schilcher, F. Koszik, A. Schneeberger, G. Stingl, M. L. Birnstiel, and T. Schweighofer. 1995. Priming of tumor specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells. three consecutive stages may be required for successful tumor vaccination. Proc. Natl. Acad. Sci. USA 92:5540.
39. Matzinger, P 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991.
40. Chicz, R. M., R. G. Urban, J. C. Gorga, D. A. A. Vignali, W. S. Lane, and J. L. Strominger. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:27.
41. Newcomb, J. R., and P. Cresswell. 1993. Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated αβ dimers. J. Immunol. 150:499.
42. Lanzavecchia, A. 1995. How can cryptic epitopes trigger autoimmunity? J. Exp. Med 181:1945
43. Pardoll, D. M. 1995. Paracrine cytokine adjuvants in cancer immunotherapy. Annu. Rev. Immunol. 13:399.
44. Mukherji, B., A. Guha, N G. Chakraborty, M. Sivanandham, A. L. Nashed, J. Sporn, and M. T. Ergin. 1989. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. J. Exp. Med. 169:1961.
45. Moore, K. W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165.
46. Becker, J. C., C. Czerny, and E B. Bröcker. 1994. Maintenance of clonal anergy by endogenously produced IL-10. Int. Immunol 6:1605.